Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

The 0.05% dutasteride topical solution effectively promotes hair growth with fewer side effects than oral treatments.

Tofacitinib and methotrexate successfully treated a woman's severe skin, joint, and hair loss issues.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

Future alopecia treatments will improve with targeted therapies and personalized approaches.

Ocrelizumab helped control lupus in a pregnant patient, leading to the birth of a healthy baby.

Topical treatments for hair loss can be effective but need careful safety evaluation.

Certain genetic mutations can lower bad cholesterol and reduce heart disease risk, leading to effective cholesterol-lowering drugs.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Ritlecitinib helped most alopecia areata patients regrow hair by Week 48.

Platelet-rich plasma therapy is effective and safe for skin regeneration and anti-aging.

Using real-time ultrasound during gluteal fat grafting is safe and reduces complication risks.

Finasteride effectively reduces prostate size and lowers surgery risk in men with benign prostatic hyperplasia.

Ustekinumab helped three kids with alopecia areata regrow hair.

Upadacitinib is effective and safe for treating severe alopecia areata in teens.

Triptorelin effectively treats central precocious puberty in Chinese children with minimal side effects.

It's generally safe to have most skin procedures after isotretinoin, but avoid aggressive treatments and use a lower dose.

Topical calcineurin inhibitors might be safer than steroids for scarring alopecia, but more research is needed.

Low-dose oral minoxidil does not significantly affect blood pressure in patients with hair loss and hypertension.

JAK inhibitors may help treat both alopecia areata and vitiligo, but more research is needed.

Low-dose oral minoxidil may help with hair loss, but more research is needed.

PRP injections improve skin appearance and are safe for treating morphea.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Both 5% minoxidil solution and milky lotion effectively and safely treat male hair loss, with the lotion being a good alternative for those sensitive to certain ingredients.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

The drug IPI-926 is safe at 160 mg daily and may help treat certain tumors, especially basal cell carcinoma.

The treatment combining docetaxel, cisplatin, and 5-FU is feasible and effective for advanced head and neck cancer.

Oral minoxidil promotes hair growth but may cause side effects; needs monitoring.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.